Supplier Type
- Trader
- custom synthesis
- contract manufacturer
- Reagent
- Manufacturer
Supplier Region
- Mumbai(31)
- Tamil Nadu(1)
- New Delhi(3)
- Hyderabad(18)
- Maharashtra(13)
- Kolkata(3)
- Andhra Pradesh(1)
- Gujarat(20)
- Bangalore(2)
- Telangana(1)
- Pune(2)
- Vadodara(6)
- Ahmedabad(5)
- Karnataka(6)
- Delhi(12)
- Uttar Pradesh(4)
- West Bengal(1)
- Nagpur(1)
Purity
- Salicylic Acid
- Rasagiline Mesylate Impurity C
- NLT 95%
- NLT 90%
- More than 98%
- more than 95%
- more than 90%
- MINIMUM 99%
- Min 98 %
- Mesalazine EP Impurity H
- Mathadone (M225865) impurity. Used in synthesis of methadone, antispasmodics and other pharmaceutica
- Greater than 99%
- Dipropargyl r- amino indane
- Dapagliflozin Intermediate, Dapagliflozin Impurity
- API Impurity / In-house working standard
- Acetylsalicylic Acid EP Impurity C
- 99.98%
- 99.95%
- 99.91%
- >99.9%
- 99.88%
- 99.86%
- 99.85%
- 99.84%
- 99.81%
- 99.73%
- 99.70%
- 99.61%
- 99.47%
- 99.42%
- 99.40%
- 99.29%
- 99.28%
- 99.27%
- 99.21%
- 99.10%
- 99.00%
- 99.0%
- 99% min
- >99%
- > 99%
- 99%
- 98=%
- 98+
- 98.88%
- 98.65%
- 98.60%
- 98.54%
- 98.53%
- 98.5%
- 98.5
- 98.18%
- 98.12%
- 98.08%
- 98.00%
- 98% Min.
- 98% Min
- 98%
- 98 %
- 97-99%
- 97.61%
- 97.57%
- > 97.5 %
- 97.00%
- 97% min
- 97%
- >97%
- 97 %
- 96.80%
- 96.5 - 103.5 %
- 96.40%
- 96.39%
- 96%
- 95-98%
- 95.20%
- 95.16%
- 95.00%
- 95% & 99%
- 95% & 97%
- 95% & 2.0M
- 95% & 1.0M
- 95%
- >95%
- 95 %
- 94.34%
- 94.00%
- 92-95%
- >92%
- 91.87%
- 90%-95%
- >90%
- 90%
- 90 % Above
- 90 %
- 85% DYE CONTENT
- 84.49%
- 8%
- 60-65%
- 50%
- 40%
- 4%/8% & 1.6M
- 3.2M
- 3.0M
- 25.0 - 50.0 %
- 25%/40%/95%/99% & 0.6M/2.15M
- 25% & 1.0M/1.8M
- 25% & 1.0M
- 25%
- 25 MG 50 MG 100 MG 250 MG EXTRA
- 21%/25%
- 20%/97% & 1.0M
- 20%/95% & 1.0M
- 20%/24%
- 20% /25%/ 1.2M/1.4M
- 20% & 2.0M
- 20%
- 2.0M
- 15%/23%/33%
- 15%/20%/23%/30% & 1.6M
- 15%
- 12%/15%
- 12%
- 100%
- 10%/99%
- 10% & 2.0M
- 1.8M/ 2.0M
- 1.8M
- 1.3M
- 1.2M
- 1.0M/3.0M/ 3.2M
- 1.0M/3.0M
- 1.0M/2.0M/ 7.0M
- 1.0M/2.0M/ 2.9M/3.0M
- 1.0M/2.0M
- 1.0M/0.5M
- 1.0M
- 0.7M in
- 0.5M/2.0M/ 2.8M
- 0.5M/1.0M/ 3.0M/3.4M
- 0.5M/1.0M/ 2.0M
- 0.5M/1.0M
- 0.5M in
- 0.5M
- 0.50M
- 0.25M
- 0.1M
- 0.04%
- (R)-N,N-di(prop-2-yn-1-yl)-2,3- dihydro-1
Package
- 100mg
- 2.5501e+00925 MG 50 MG 100 MG 250 MG EXTRA
- 25mg
- 50mg
- 250mg
- 500mg
- 1g
- 1gm
- 5g
- 10g
- 25g
- 50g
- 100ml
- 100g
- 500g
- 500ml
- 1L
- 1kg
- 5kg
- 10kg
- 25kg
- 50kg
- 100kg
- 500kg
- 1MT
- 1and gm
- 95NLT %
- 250250 mg.
- 11Between 1 gm to 1 MT (As per availability)
-
Manganate(1-), hexakis[μ-(acetato-κO:κO')]bis(acetato-κO)-μ3-oxotri-, hydrogen (1:1), homopolymer
26935-72-8
-
Diloxanide furoate
3736-81-0
-
((3AS,5R,6S,6aS)-6-hydroxy-2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxol-5-yl)(morpholino)methanone
1103738-19-7
-
Ammonium ferric citrate
1185-57-5
-
Mometasone furoate
83919-23-7
-
6-HYDROXY-2,4,5-TRIAMINOPYRIMIDINE SULFATE
39267-74-8
-
4,6-Dichloro-5-(2-methoxyphenoxy)-2,2'-bipyrimidine
150728-13-5
-
Cyclopropylacetylene
6746-94-7
-
1,2,4-Triazole
288-88-0
-
4-Bromomethyl-2-cyanobiphenyl
114772-54-2
1-(3,5-Dichloro-4-fluorophenyl)-2,2,2-trifluoroethanone 1190865-44-1
Ammonium iron(III) citrate 1185-57-5
Mometasone furoate 83919-23-7
Iron(III) chloride 7705-08-0
Iron(III) chloride 7705-08-0
Iron(III) oxide 1309-37-1
Lanthanum(III) trifluoromethanesulfonate 52093-26-2
